Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab Cover

.blurhash-client-img { display: none !important; }

Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab

Radiology and Oncology

Volume 59 (2025): Issue 4 (December 2025)

By: Erdem Ozkan, Murathan Koksal, Bunyamin Ece, Mustafa Koyun, Omer Faruk Kuzu, Yusuf Acikgoz and Efnan Algin

Open Access

|Dec 2025

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/raon-2025-0065 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 624 - 634

Submitted on: Jun 25, 2025

Accepted on: Oct 20, 2025

Published on: Dec 16, 2025

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

renal cell carcinoma,

low muscle mass,

computed tomography,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2025 Erdem Ozkan, Murathan Koksal, Bunyamin Ece, Mustafa Koyun, Omer Faruk Kuzu, Yusuf Acikgoz, Efnan Algin, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 59 (2025): Issue 4 (December 2025)